InvestorsHub Logo
Followers 0
Posts 1531
Boards Moderated 0
Alias Born 01/04/2017

Re: None

Wednesday, 10/04/2017 5:38:37 PM

Wednesday, October 04, 2017 5:38:37 PM

Post# of 108192
If Advaxis' formulations are cheaper than the alternatives and more effective then the only limits to market penetration are production capacity and distribution. we know that production is readily scaleable and we can assume that lenders will be willing to finance additional plant if the market warrants.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News